Companies Cryptocurrencies
Natera Inc
Natera Inc
Exchange: Nasdaq Global Select
IPO Date: 02/07/2015
CEO: Mr. Steven Chapman
Diagnostics & Research Healthcare 🔗
  • NTRA
  • price
  • market cap
  • changes
If you bought

shares of Natera Inc (NTRA) on
You would have made
Old Price $12 Current Price $12

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. The company is headquartered in San Carlos, California and currently employs 975 full-time employees. The firm is engaged in the discovery, development and commercialization of genetic testing services. The company offers Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier’s children; Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle to select embryos with the probability of becoming healthy children; Anora Products of Conception test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing, to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mother’s blood and a blood sample from the alleged father(s).

Address: 201 Industrial Rd Ste 410 San Carlos CALIFORNIA 94070

Stay updated.